Regulatory Impact on Target Marketing

Otolith Labs
Student Price: 
$11.00 (€9.76)
Area of Study: 
North America
Regulatory Enviornment, Legal, Cost Benefit Analysis, CBA, Feasibility, Market Share
Distributed by the Global Jesuit Case Series
Average rating: 

Payor reimbursement is critical to the business model of a medical device company. The gold standard for reimbursement is a CPT code that assigns a fixed number of Relative Value Units (RVUs) to a device, which then must be adhered to by all payors (i.e., negotiation occurs once). An HCPCS code is much easier to get, but reimbursement must be negotiated with each insurance company individually. Ultimately, the question at hand is:  what is the best path forward for Otolith Labs post-FDA approval?

“Which type of code should we lobby for, and when does the lobbying effort begin?”

Watch Videos

Add review

Vertical Tabs

Revision information
Provide an explanation of the changes you are making. This will help other authors understand your motivations.